Cargando…
Cellular and vaccine therapeutic approaches for gliomas
Despite new additions to the standard of care therapy for high grade primary malignant brain tumors, the prognosis for patients with this disease is still poor. A small contingent of clinical researchers are focusing their efforts on testing the safety, feasibility and efficacy of experimental activ...
Autores principales: | Hickey, Michelle J, Malone, Colin C, Erickson, Kate L, Jadus, Martin R, Prins, Robert M, Liau, Linda M, Kruse, Carol A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964608/ https://www.ncbi.nlm.nih.gov/pubmed/20946667 http://dx.doi.org/10.1186/1479-5876-8-100 |
Ejemplares similares
-
Exploring the Therapeutic Efficacy of Glioma Vaccines Based on Allo- and Syngeneic Antigens and Distinct Immunological Costimulation Activators
por: Stathopoulos, Apostolos, et al.
Publicado: (2012) -
Combining cellular and gene therapy approaches for treatment of intracranial tumors
por: Hickey, Michelle J, et al.
Publicado: (2013) -
Adjuvant inhibition of iAPC function in the tumor microenvironment promotes therapeutic immunity in the setting of vaccination-induced T cell anti-tumor response
por: Antonios, Joseph, et al.
Publicado: (2015) -
Differential Glioma-Associated Tumor Antigen Expression Profiles of Human Glioma Cells Grown in Hypoxia
por: Ge, Lisheng, et al.
Publicado: (2012) -
Dendritic Cell Vaccination in Conjunction with a TLR Agonist Polarizes Interferon Immune Responses in Malignant Glioma Patients
por: Everson, Richard G., et al.
Publicado: (2023)